tiprankstipranks
Zydus Lifesciences Limited (IN:ZYDUSLIFE)
:ZYDUSLIFE
India Market
Want to see IN:ZYDUSLIFE full AI Analyst Report?

Zydus Lifesciences Limited (ZYDUSLIFE) Stock Forecast & Price Target

8 Followers
See the Price Targets and Ratings of:

ZYDUSLIFE Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Zydus
Lifesciences Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZYDUSLIFE Stock 12 Month Forecast

There Are No Analyst Ratings for IN:ZYDUSLIFE In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ZYDUSLIFE Financial Forecast

ZYDUSLIFE Earnings Forecast

The previous quarter’s earnings for ZYDUSLIFE were ₹11.00.
The previous quarter’s earnings for ZYDUSLIFE were ₹11.00.

ZYDUSLIFE Sales Forecast

The previous quarter’s earnings for ZYDUSLIFE were ₹75.87B.
The previous quarter’s earnings for ZYDUSLIFE were ₹75.87B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Prabhudas Lilladher Analyst forecast on IN:ZYDUSLIFE
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹1,020
Buy
10.65%
Upside
Reiterated
02/11/26
Prabhudas Lilladher Sticks to Their Buy Rating for Zydus Lifesciences Limited (ZYDUSLIFE)
J.P. Morgan Analyst forecast on IN:ZYDUSLIFE
J.P. Morgan
J.P. Morgan
₹1,010
Hold
9.57%
Upside
Reiterated
02/11/26
J.P. Morgan Reaffirms Their Hold Rating on Zydus Lifesciences Limited (ZYDUSLIFE)
HSBC
₹920₹965
Hold
4.69%
Upside
Reiterated
10/14/25
HSBC Keeps Their Hold Rating on Zydus Lifesciences Limited (ZYDUSLIFE)
Macquarie
₹1,365₹1,110
Buy
20.42%
Upside
Reiterated
07/08/25
Zydus Lifesciences Limited (ZYDUSLIFE) Receives a Buy from Macquarie
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Prabhudas Lilladher Analyst forecast on IN:ZYDUSLIFE
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹1,020
Buy
10.65%
Upside
Reiterated
02/11/26
Prabhudas Lilladher Sticks to Their Buy Rating for Zydus Lifesciences Limited (ZYDUSLIFE)
J.P. Morgan Analyst forecast on IN:ZYDUSLIFE
J.P. Morgan
J.P. Morgan
₹1,010
Hold
9.57%
Upside
Reiterated
02/11/26
J.P. Morgan Reaffirms Their Hold Rating on Zydus Lifesciences Limited (ZYDUSLIFE)
HSBC
₹920₹965
Hold
4.69%
Upside
Reiterated
10/14/25
HSBC Keeps Their Hold Rating on Zydus Lifesciences Limited (ZYDUSLIFE)
Macquarie
₹1,365₹1,110
Buy
20.42%
Upside
Reiterated
07/08/25
Zydus Lifesciences Limited (ZYDUSLIFE) Receives a Buy from Macquarie
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zydus Lifesciences Limited

3 Months
Success Rate
2/2 ratings generated profit
100%
Average Return
+6.10%
Copying Kunal Dhamesha's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.10% per trade.
1 Year
Success Rate
2/2 ratings generated profit
100%
Average Return
+4.70%
Copying Kunal Dhamesha's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +4.70% per trade.
2 Years
Success Rate
2/2 ratings generated profit
100%
Average Return
+12.95%
Copying Kunal Dhamesha's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZYDUSLIFE Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
2
2
2
0
In the current month, ZYDUSLIFE has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ZYDUSLIFE average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ZYDUSLIFE Stock Forecast FAQ

What is IN:ZYDUSLIFE’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:ZYDUSLIFE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:ZYDUSLIFE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Zydus Lifesciences Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Zydus Lifesciences Limited’s share price target?
      Currently, no data Available
      What do analysts say about Zydus Lifesciences Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Zydus Lifesciences Limited?
      To buy shares of IN:ZYDUSLIFE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.